{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:12:07Z","timestamp":1791306727385,"version":"4.3.1"},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T00:00:00Z","timestamp":1419811200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0116306","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T18:59:27Z","timestamp":1419879567000},"page":"e116306","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":64,"title":["The Immunologic Effects of Mesalamine in Treated HIV-Infected Individuals with Incomplete CD4+ T Cell Recovery: A Randomized Crossover Trial"],"prefix":"10.1371","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct01090102","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Ma","family":"Somsouk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Dunham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Albright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abdel-Mohsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teri","family":"Liegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lifson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Piatak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gorelick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuaner","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla Y.","family":"Hsue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey N.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Deeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"McCune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,12,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"a3172","DOI":"10.1136\/bmj.a3172","article-title":"HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity","volume":"338","author":"SG Deeks","year":"2009","journal-title":"Bmj"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.7326\/0003-4819-146-2-200701160-00003","article-title":"Survival of persons with and without HIV infection in Denmark, 1995\u20132005","volume":"146","author":"N Lohse","year":"2007","journal-title":"Ann Intern Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/QAI.0b013e318134257a","article-title":"HIV-infected adults with a CD4 cell count greater than 500 cells\/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population","volume":"46","author":"C Lewden","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","article-title":"Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies","volume":"372","author":"Collaboration Antiretroviral Therapy Cohort","year":"2008","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"JM Brenchley","year":"2006","journal-title":"Nat Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1086\/597476","article-title":"Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection","volume":"199","author":"W Jiang","year":"2009","journal-title":"J Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1097\/QAD.0b013e3283112d29","article-title":"Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy","volume":"22","author":"G Marchetti","year":"2008","journal-title":"Aids"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1086\/655229","article-title":"Persistent Microbial Translocation and Immune Activation in HIV-1-Infected South Africans Receiving Combination Antiretroviral Therapy","volume":"202","author":"E Cassol","year":"2010","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e1001052","DOI":"10.1371\/journal.ppat.1001052","article-title":"Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections","volume":"6","author":"JD Estes","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1086\/525046","article-title":"Simian immunodeficiency virus-induced intestinal cell apoptosis is the underlying mechanism of the regenerative enteropathy of early infection","volume":"197","author":"Q Li","year":"2008","journal-title":"J Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1172\/JCI75090","article-title":"Early microbial translocation blockade reduces SIV-mediated inflammation and viral replication","volume":"124","author":"J Kristoff","year":"2014","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1086\/374786","article-title":"T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy","volume":"187","author":"PW Hunt","year":"2003","journal-title":"J Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"LH Kuller","year":"2008","journal-title":"PLoS Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.2337\/dc10-0633","article-title":"Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy","volume":"33","author":"TT Brown","year":"2010","journal-title":"Diabetes Care"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/QAD.0b013e32833ad914","article-title":"Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection","volume":"24","author":"ES Ford","year":"2010","journal-title":"AIDS"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/QAI.0b013e3181e66216","article-title":"Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort","volume":"55","author":"PC Tien","year":"2010","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/cid\/cir989","article-title":"Does an Index Composed of Clinical Data Reflect Effects of Inflammation, Coagulation, and Monocyte Activation on Mortality Among Those Aging With HIV?","volume":"54","author":"AC Justice","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Kamm MA, Sandborn WJ, Gassull M, Schreiber S, Jackowski L, et al. (2007) Once-daily, high-concentration MMX mesalamine in active ulcerative colitis. Gastroenterology 132: 66\u201375; quiz 432\u2013433.","DOI":"10.1053\/j.gastro.2006.10.011"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Sutherland L, Macdonald JK (2006) Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev: CD000543.","DOI":"10.1002\/14651858.CD000543.pub2"},{"key":"ref20","unstructured":"Anton P, Elliot J, Quigley MF, Olsson J, Tiang P, et al. (2001) Use of Asacol, a mucosal anti-inflammatory medication, is safe as adjunctive HIV therapy and is associated with mild decreases in mucosal RANTES. 1st IAS Conference on HIV Pathogenesis and Treatment, July, Buenos Aires A663."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e15533","DOI":"10.1371\/journal.pone.0015533","article-title":"Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation","volume":"5","author":"A Kamat","year":"2010","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10620-006-3102-6","article-title":"Double-blind pilot study of mesalamine vs. placebo for treatment of chronic diarrhea and nonspecific colitis in immunocompetent HIV patients","volume":"51","author":"M Rodriguez-Torres","year":"2006","journal-title":"Dig Dis Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"6557","DOI":"10.1128\/JVI.00073-11","article-title":"An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses","volume":"85","author":"FO Pettersen","year":"2011","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/01.aids.0000218544.54586.f1","article-title":"Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment","volume":"20","author":"D Kvale","year":"2006","journal-title":"AIDS"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/00002030-200404090-00015","article-title":"Treatment with type-2 selective and non-selective cyclooxygenase inhibitors improves T-cell proliferation in HIV-infected patients on highly active antiretroviral therapy","volume":"18","author":"CC Johansson","year":"2004","journal-title":"AIDS"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/gut.47.3.410","article-title":"Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis","volume":"47","author":"G Frieri","year":"2000","journal-title":"Gut"},{"key":"ref27","first-page":"38","article-title":"Encapsulated mesalamine granules (Apriso) for ulcerative colitis","volume":"51","year":"2009","journal-title":"Med Lett Drugs Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-2036.2010.04438.x","article-title":"Clinical trial: once-daily mesalamine granules for maintenance of remission of ulcerative colitis - a 6-month placebo-controlled trial","volume":"32","author":"GR Lichtenstein","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1345\/aph.1R171","article-title":"Extended-release mesalamine granules for ulcerative colitis","volume":"46","author":"BL Love","year":"2012","journal-title":"Ann Pharmacother"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1128\/JCM.41.10.4531-4536.2003","article-title":"New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma","volume":"41","author":"S Palmer","year":"2003","journal-title":"J Clin Microbiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1093\/nar\/20.19.5149","article-title":"Synthesis of oligodeoxyribonucleotides containing degenerate bases and their use as primers in the polymerase chain reaction","volume":"20","author":"PK Lin","year":"1992","journal-title":"Nucleic Acids Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/infdis\/jiu115","article-title":"The Kynurenine Pathway of Tryptophan Catabolism, CD4+ T-Cell Recovery, and Mortality Among HIV-Infected Ugandans Initiating Antiretroviral Therapy","volume":"210","author":"H Byakwaga","year":"2014","journal-title":"J Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1097\/QAD.0b013e32832e7140","article-title":"Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients","volume":"23","author":"PY Hsue","year":"2009","journal-title":"Aids"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Ho JE, Scherzer R, Hecht FM, Maka K, Selby V, et al. (2012) The association of CD4+ T-cell count on cardiovascular risk in treated HIV disease. Aids.","DOI":"10.1097\/QAD.0b013e328352ce54"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/CIRCULATIONAHA.110.953653","article-title":"Microvascular function predicts cardiovascular events in primary prevention: long-term results from the Firefighters and Their Endothelium (FATE) study","volume":"123","author":"TJ Anderson","year":"2011","journal-title":"Circulation"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1161\/ATVBAHA.107.147322","article-title":"Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery","volume":"27","author":"AL Huang","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.jacc.2008.02.044","article-title":"Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation","volume":"51","author":"AE Donald","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1182\/blood-2008-10-182709","article-title":"Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control","volume":"113","author":"AL Ferre","year":"2009","journal-title":"Blood"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-1759(03)00255-2","article-title":"Optimization of methods to assess human mucosal T-cell responses to HIV infection","volume":"279","author":"BL Shacklett","year":"2003","journal-title":"J Immunol Methods"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/13550280701327038","article-title":"Human immunodeficiency virus type 1 RNA Levels in different regions of human brain: quantification using real-time reverse transcriptase-polymerase chain reaction","volume":"13","author":"AM Kumar","year":"2007","journal-title":"J Neurovirol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF01965001","article-title":"Enhanced formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn\u2019s disease: inhibition by sulfasalazine and 5-aminosalicylic acid","volume":"18","author":"BM Peskar","year":"1986","journal-title":"Agents Actions"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/BF01296156","article-title":"Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid","volume":"32","author":"OH Nielsen","year":"1987","journal-title":"Dig Dis Sci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1053\/gast.2000.19458","article-title":"Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta","volume":"119","author":"CK Weber","year":"2000","journal-title":"Gastroenterology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1097\/MIB.0b013e318297d741","article-title":"Antioxidant properties of mesalamine in colitis inhibit phosphoinositide 3-kinase signaling in progenitor cells","volume":"19","author":"E Managlia","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1136\/gutjnl-2011-301626","article-title":"5-Aminosalicylic acid inhibits cell cycle progression in a phospholipase D dependent manner in colorectal cancer","volume":"61","author":"B Baan","year":"2012","journal-title":"Gut"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejphar.2009.07.009","article-title":"An anti-inflammatory mechanism of taurine conjugated 5-aminosalicylic acid against experimental colitis: taurine chloramine potentiates inhibitory effect of 5-aminosalicylic acid on IL-1beta-mediated NFkappaB activation","volume":"618","author":"K Joo","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1084\/jem.20041948","article-title":"Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma","volume":"201","author":"C Rousseaux","year":"2005","journal-title":"J Exp Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1471-4159.2005.03267.x","article-title":"Human immunodeficiency virus type 1 envelope glycoprotein 120 induces cyclooxygenase-2 expression in neuroblastoma cells through a nuclear factor-kappaB and activating protein-1 mediated mechanism","volume":"94","author":"S Alvarez","year":"2005","journal-title":"J Neurochem"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1189\/jlb.68.3.423","article-title":"Induction of cyclooxygenase-2 expression during HIV-1-infected monocyte-derived macrophage and human brain microvascular endothelial cell interactions","volume":"68","author":"CF Pereira","year":"2000","journal-title":"J Leukoc Biol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1006\/bbrc.2000.3160","article-title":"Apoptosis induced by gp120 in the neocortex of rat involves enhanced expression of cyclooxygenase type 2 and is prevented by NMDA receptor antagonists and by the 21-aminosteroid U-74389G","volume":"274","author":"MT Corasaniti","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bcp.2007.09.020","article-title":"Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid","volume":"75","author":"C Stolfi","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/carcin\/bgr306","article-title":"The influence of 5-aminosalicylic acid on the progression of colorectal adenomas via the beta-catenin signaling pathway","volume":"33","author":"J Munding","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/QAI.0b013e31828a292c","article-title":"Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study","volume":"63","author":"M O\u2019Brien","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Sandler NG, Zhang X, Bosch RJ, Funderburg NT, Choi AI, et al. (2014) Sevelamer Does Not Decrease Lipopolysaccharide or Soluble CD14 Levels But Decreases Soluble Tissue Factor, Low-Density Lipoprotein (LDL) Cholesterol, and Oxidized LDL Cholesterol Levels in Individuals With Untreated HIV Infection. J Infect Dis.","DOI":"10.1093\/infdis\/jiu305"},{"key":"ref55","unstructured":"Tenorio AR, Wilson CC, Chan ES, Bosch RJ, Macatangay BJ, et al. (2014) Rifaximin has marginal impact on immune activation in immune non-responders to ART- ACTG A5286. Conference on Retroviruses and Opportunistic Infection Oral Presentation: Abs. 339."},{"key":"ref56","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/mi.2011.15","article-title":"Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the \u201cCOPA\u201d pilot randomized trial","volume":"4","author":"A Gori","year":"2011","journal-title":"Mucosal Immunol"},{"key":"ref57","unstructured":"Stiksrud B, Nowak P, Kvale D, Thalme A, Birkeland S, et al. (2014) Reduced D-dimer levels and inflammation markers after probiotic supplement in HIV-infected on ART. Conference on Retroviruses and Opportunistic Infection: Abs. 342."},{"key":"ref58","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nm.2111","article-title":"HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects","volume":"16","author":"MJ Buzon","year":"2010","journal-title":"Nat Med"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/infdis\/jir060","article-title":"Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy","volume":"203","author":"PW Hunt","year":"2011","journal-title":"J Infect Dis"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/ibd.21903","article-title":"Serological antibodies in inflammatory bowel disease: a systematic review","volume":"18","author":"L Prideaux","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/COH.0b013e32833647d9","article-title":"Th17, gut, and HIV: therapeutic implications","volume":"5","author":"PW Hunt","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/mi.2012.72","article-title":"A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis","volume":"5","author":"CJ Kim","year":"2012","journal-title":"Mucosal Immunol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"C Abraham","year":"2009","journal-title":"N Engl J Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0116306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T05:43:46Z","timestamp":1690782226000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0116306"}},"subtitle":[],"editor":[{"given":"Javier R.","family":"Lama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,29]]},"references-count":63,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0116306","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,29]]}}}